Didroevocarpine induces cytotoxicity in acute myeloid leukemia via suppressing the mTORC1/2 activity[1].
[1]. Zhang S, et al. Targeting of mTORC1/2 by didroevocarpine induces cytotoxicity in acute myeloid leukemia.J Cell Psiol. 2019;234(8):13032-13041.
















